Reverse Engineering & Malware Analysis is a commercial malware analysis solution by B.U. Creative. TRISIS / TRITON / HatMan Malware Repository is a free malware analysis solution. Features, integrations, deployment and the company behind each one, side by side.
Malware analysis & reverse engineering service producing IOCs, YARA/Sigma rules.
Repository of TRISIS/TRITON/HatMan malware samples and decompiled sources targeting ICS Triconex SIS controllers.
See more solutions in this category, or build a security stack from your picks.
Based on what each listing shows: deployment, company size, price and open source.
TRISIS / TRITON / HatMan Malware Repository fits if you need a free product and you want an open-source product.
Common questions when comparing Reverse Engineering & Malware Analysis vs TRISIS / TRITON / HatMan Malware Repository for malware analysis.
Reverse Engineering & Malware Analysis: Malware analysis & reverse engineering service producing IOCs, YARA/Sigma rules. Built by B.U. Creative.
TRISIS / TRITON / HatMan Malware Repository: Repository of TRISIS/TRITON/HatMan malware samples and decompiled sources targeting ICS Triconex SIS controllers.
The table above shows where their features, integrations, deployment and company size fit differ.
Reverse Engineering & Malware Analysis is made by B.U. Creative. TRISIS / TRITON / HatMan Malware Repository is open-source with 243 GitHub stars. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.
Often, yes. Reverse Engineering & Malware Analysis and TRISIS / TRITON / HatMan Malware Repository are both Malware Analysis products, and both cover Binary Analysis. Key differences: Reverse Engineering & Malware Analysis is Commercial while TRISIS / TRITON / HatMan Malware Repository is Free, TRISIS / TRITON / HatMan Malware Repository is open-source. Use the table above to see where features, deployment and company size fit differ.
No Malware Analysis shortlist yet. This is the closest one.
Updated 2026-11-02
See the shortlist
